Study of glucocorticoid-induced osteoporosis prevention in patients with glomerulonephritis
Phase 3
- Conditions
- glomerulonephritis
- Registration Number
- JPRN-UMIN000022873
- Lead Sponsor
- Kakogawa central city hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Cases where no consent is obtained. 2.Patients allergic to alendronate sodium or denosumab. 3.Patients pregnant or potential. 4.Other cases where physicians regard as inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of bone mineral density
- Secondary Outcome Measures
Name Time Method change of bone turnover markers, proteinuria, kidney function